Cytiva HiTrap™ MabSelect™ SuRe™ LX Columns

Polyclonal antibodies, monoclonal antibodies (mAb), and antibody fragments are usually purified by affinity chromatography. Resins containing an immobilized ligand (e.g., protein A, protein G, or protein L) are used to capture antibodies and antibody fragments.

Product Code	Brand	Volume (Metric) Bed	Quantity
16437695	Cytiva 29268402	1 mL	5/Pk.
16417695	Cytiva 29130609	1 mL	10/Pk.
16427695	Cytiva 29157185	5 mL	5/Pk.

Description

• Novel, alkali-tolerant rProtein A ligand withstands rigorous CIP and sanitization procedures with 0.1 to 0.5 M NaOH
• High dynamic binding capacity (DBC) for high titer cultures reduces process time and amount of medium used
• Generic elution profile for different monoclonal antibodies enables platform approach to purification
• High-flow agarose matrix allows the processing of large feed volumes
• Reduces the risk of product contamination and carryover
• Improves performance and reduces overall costs

Specifications

• Product Type: Antibody Purification Column
• Ligand: Protein A
• Purification Target: Human IgG

• Stationary Phase: MabSelect SuRe LX
• Particle Size: 85 μm
• For Use With (Application): Purification of Human IgG

Safety and Handling

Product Identifier

• HiTrap MabSelect SuRe LX

Signal Word

• Warning

Hazard Category

• Flammable liquid Category 3

Hazard Statement

• H226-Flammable liquid and vapour.

Precautionary Statement

• P241-Use explosion-proof electrical/ventilating/lighting/ equipment.
• P280-Wear protective gloves/protective clothing/eye protection/face protection.
• P305+P351+P338-IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
• P501b-Dispose of contents/container in accordance with local/regional/national/international regulations.

Supplemental information

• MIXTURE LIST-Contains : ethanol
• UNKNOWN ACUTE-16.5 per cent of the mixture consists of component(s) of unknown acute toxicity.